dm+d
416385001
Articles
Treating urinary disorders during breastfeeding
21 March 2023Oxybutynin is preferred for urinary frequency, enuresis, and incontinence during breastfeeding. Recommendations apply to full term and healthy infants only.
Medicine Compliance Aid Stability
EmselexAspire Pharma
Aspire Pharma
Emselex
Tablets m/r 7.5mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from light
15 November 2022
Lactation Safety Information
Oxybutynin
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties although long half-life increases risk of accumulation in breastfed infants
Monitor infant for anticholinergic effects, e.g. urinary retention, colic and constipation
7 August 2020